Deoxycytidine kinase can be also potentiated by the G-protein activator NaF in cells

6Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Recently, it has been shown, that 2-Chloro-deoyadenoise (1), a series of analogies, an other DNA synthesis inhibitors, increased the deoxycytidine kinase (dCK) enzyme activity in different cells, without influencing thymidine kinase isoenzymes (TK1, TK2), dCMP-deaminase and thymidylate synthase (TS) activities (2,3). The dCK activity was 2-4 times higher in analogue treated cells, than in controls, which can not be explained by metabolic pool imbalance induced by the drugs. New mRNA and protein synthesis of dCK could not be detected, thus post-translational modification has been suggested for potenciatiation the activity of the dCK (1). Because secondary modifications of enzymes usually involve the signalling processes in cells, the universal G-protein activator fluorine ions were tested. dCK activity of human lymphnode lymphocytes were increased 2-times, if cells were incubated in the presence of NaF for 1-2 hrs in cultures, while TK activity was not changed. The formation of dUTP from dCyd, was also enhanced by NaF, in paralel of dCK potentiation.

Cite

CITATION STYLE

APA

Staub, M., Csapó, Z., Spasokukotskaja, T., & Sasvári-Székely, M. (1998). Deoxycytidine kinase can be also potentiated by the G-protein activator NaF in cells. In Advances in Experimental Medicine and Biology (Vol. 431, pp. 425–428). Springer New York LLC. https://doi.org/10.1007/978-1-4615-5381-6_83

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free